CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Changes in the Mean Corpuscular Volume after Capecitabine Treatment Are Associated with Clinical Response and Survival in Patients with Advanced Gastric Cancer

Hyun Ae Jung, Hyun-Jun Kim, Chi Hoon Maeng, Se Hoon Park, Jeeyun Lee, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang

Cancer Research and Treatment. 2015;47(1):72-77. Published online 2014 August 21 DOI: https://doi.org/10.4143/crt.2013.172

Changes in the Mean Corpuscular Volume after Capecitabine Treatment Are Associated with Clinical Response and Survival in Patients with Advanced Gastric Cancer

Hyun Ae Jung, Hyun-Jun Kim, Chi Hoon Maeng, Se Hoon Park, Jeeyun Lee, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang

Cancer Research and Treatment. 1970;47(1):72-77

Link1

Link2 Link3

Capecitabine and Regorafenib-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer

M.A. Barbera, G. Frega, A. Palloni, F. Abbati, G. Biasco, I. Garajova

Annals of Oncology. 2016;27:iv52

Link1 Link2 Link3

Increased mean corpuscular volume of erythrocytes predicts the response to metronomic cyclophosphamide, capecitabine and bevacizumab treatment: Is it true for capecitabine treatment or more?

Cagatay Arslan, Kadri Altundag

The Breast. 2012;21(4):612-613

Link1 Link2

Increased Mean Corpuscular Volume of Red Blood Cells in Patients Treated with Capecitabine for Advanced Breast and Colon Cancer

Laura Scarabelli, Filippo Giovanardi, Erika Gervasi, Giuseppe Prati, Debora Pezzuolo, Laura Scaltriti

Chemotherapy. 2013;59(5):369-372

Link1 Link2 Link3

Increased Mean Corpuscular Volume of Erythrocytes during Capecitabine Treatment: A Simple Surrogate Marker for Clinical Response

Cagatay Arslan, Sercan Aksoy, Omer Dizdar, Mevlut Kurt, Nilufer Guler, Yavuz Ozisik, Ibrahim Gullu, Kadri Altundag

Tumori Journal. 2011;97(6):711-716

Link1 Link2

Capecitabine for the treatment for advanced gastric cancer: efficacy, safety and ethnicity

Y. Ma, L. Tang, H.-X. Wang, Y.-C. Xu, Y. Ma, F.-C. Zhang

Journal of Clinical Pharmacy and Therapeutics. 2011;37(3):266-275

Link1 Link2

Survival prolongation after treatment failure of first-line chemotherapy in patients with advanced gastric cancer: combined analysis of the Japan Clinical Oncology Group Trials JCOG9205 and JCOG9912

Atsuo Takashima, Narikazu Boku, Ken Kato, Kenichi Nakamura, Junki Mizusawa, Haruhiko Fukuda, Kuniaki Shirao, Yasuhiro Shimada, Atsushi Ohtsu

Gastric Cancer. 2013;17(3):522-528

Link1

Link2 Link3

Erythrocyte Mean Corpuscular Volume Change During Pemetrexed Treatment in Advanced Non Small Cell Lung Cancer Patients

S. Buti, P. Bordi, M. Tiseo, S. Panni, S. Novello, E. Bria, S.G. Rapetti, S. Pilotto, R. Camisa, A. Ardizzoni

Annals of Oncology. 2012;23:ix442

Link1 Link2

Capecitabine “metronomic” chemotherapy for palliative treatment of elderly patients with advanced gastric cancer after fluoropyrimidine-based chemotherapy

ShengLi He, Jie Shen, Liang Hong, LuMing Niu, DaoYong Niu

Medical Oncology. 2011;29(1):100-106

Link1

Link2 Link3

Factors associated with other-cause survival after gastrectomy in patients with gastric cancer

Ryota Matsui, Noriyuki Inaki, Toshikatsu Tsuji

. 2022;

Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.